Detalhe da pesquisa
1.
Evidence supports a causal association between allele-specific vitamin D receptor binding and multiple sclerosis among Europeans.
Proc Natl Acad Sci U S A
; 121(8): e2302259121, 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38346204
2.
Extended optical treatment versus early patching with an intensive patching regimen in children with amblyopia in Europe (EuPatch): a multicentre, randomised controlled trial.
Lancet
; 403(10438): 1766-1778, 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704172
3.
Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study.
Ann Neurol
; 95(3): 487-494, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38098141
4.
Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis.
Brain
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630618
5.
Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus.
Rheumatology (Oxford)
; 62(7): 2601-2610, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36370065
6.
Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis Relapse.
Ann Neurol
; 91(3): 417-423, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34984719
7.
Association between early treatment of multiple sclerosis and patient-reported outcomes: a nationwide observational cohort study.
J Neurol Neurosurg Psychiatry
; 94(4): 284-289, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36600595
8.
Comparative effectiveness of natalizumab on cognition in multiple sclerosis: A cohort study.
Mult Scler
; 29(4-5): 628-636, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36789885
9.
The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case-control study.
Mult Scler
; 29(10): 1209-1215, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37435869
10.
Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis.
Mult Scler
; 29(9): 1126-1135, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37392018
11.
A controlled, randomized phase II clinical trial for efficacy and safety evaluation of mannuronic acid in secondary progressive form of multiple sclerosis.
Int J Neurosci
; 132(4): 403-412, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32878514
12.
Depression and multiple sclerosis: A bidirectional Mendelian randomisation study.
Mult Scler
; 27(11): 1799-1802, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33605804
13.
A multiple sclerosis disease progression measure based on cumulative disability.
Mult Scler
; 27(12): 1875-1883, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33487091
14.
Accurate classification of secondary progression in multiple sclerosis using a decision tree.
Mult Scler
; 27(8): 1240-1249, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33263261
15.
Validating the diagnosis of multiple sclerosis using Swedish administrative data in Värmland County.
Acta Neurol Scand
; 144(6): 680-686, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34357597
16.
Early clinical markers of aggressive multiple sclerosis.
Brain
; 143(5): 1400-1413, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32386427
17.
Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort study.
J Neurol Neurosurg Psychiatry
; 90(7): 761-767, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30824631
18.
The landscape of multiple sclerosis registries: Strengths and limitations.
Mult Scler
; 30(3): 281-282, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38318819
19.
Cognitive function is a major determinant of income among multiple sclerosis patients in Sweden acting independently from physical disability.
Mult Scler
; 25(1): 104-112, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29143553
20.
Predicting risk of secondary progression in multiple sclerosis: A nomogram.
Mult Scler
; 25(8): 1102-1112, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29911467